HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobuyuki Yamamoto Selected Research

Vinorelbine (Navelbine)

1/2022Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy.
1/2021A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
1/2021Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR).
1/2020Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.
1/2018A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.
1/2018A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.
1/2018Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study Protocol.
1/2013Efficacy and safety of platinum combination chemotherapy re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbine.
12/2012Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: a retrospective study in Japan.
4/2012Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobuyuki Yamamoto Research Topics

Disease

195Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 07/2004
116Neoplasms (Cancer)
10/2022 - 04/2004
47Lung Neoplasms (Lung Cancer)
09/2022 - 06/2002
26Disease Progression
01/2022 - 02/2010
24Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2021 - 07/2004
19Adenocarcinoma of Lung
03/2021 - 01/2011
19Adenocarcinoma
12/2020 - 01/2008
17Neoplasm Metastasis (Metastasis)
12/2021 - 01/2010
14Diarrhea
01/2022 - 08/2009
13Interstitial Lung Diseases (Interstitial Lung Disease)
12/2020 - 05/2006
13Neutropenia
01/2020 - 07/2009
13Nausea
03/2019 - 12/2010
13Hypoxia (Hypoxemia)
02/2014 - 08/2010
11Febrile Neutropenia
10/2022 - 12/2010
10Exanthema (Rash)
01/2022 - 07/2010
10Thrombocytopenia (Thrombopenia)
01/2020 - 11/2009
8Carcinoma (Carcinomatosis)
10/2017 - 04/2010
8Breast Neoplasms (Breast Cancer)
06/2013 - 06/2002
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 12/2009
7Vomiting
03/2019 - 12/2010
6Circulating Neoplastic Cells
05/2021 - 01/2013
6Fatigue
01/2020 - 09/2013
6Anorexia
01/2020 - 08/2009
6Thymoma (Thymic Carcinoma)
06/2014 - 12/2009
5Pneumonia (Pneumonitis)
01/2022 - 09/2008
5Hypertension (High Blood Pressure)
01/2022 - 08/2013
5Neuroblastoma
07/2021 - 07/2011
5Infections
02/2021 - 04/2012
5Pain (Aches)
01/2020 - 04/2011
5Anemia
01/2020 - 11/2011
4Residual Neoplasm
07/2021 - 01/2013
4Proteinuria
01/2018 - 11/2009
4Acne Vulgaris
09/2015 - 09/2013
4Malignant Mesothelioma
03/2014 - 03/2010
3Leukopenia
01/2020 - 12/2010
3Drug-Related Side Effects and Adverse Reactions
04/2019 - 07/2008
3Brain Neoplasms (Brain Tumor)
04/2019 - 03/2016
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 07/2008
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2018 - 11/2015

Drug/Important Bio-Agent (IBA)

63ErbB Receptors (EGF Receptor)IBA
09/2022 - 05/2006
46Tyrosine Kinase InhibitorsIBA
03/2022 - 05/2006
40Cisplatin (Platino)FDA LinkGeneric
09/2022 - 07/2004
26Gefitinib (Iressa)FDA Link
09/2022 - 05/2006
26PlatinumIBA
03/2022 - 08/2007
26Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2009
25Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022 - 11/2009
25Pemetrexed (MTA)FDA Link
09/2022 - 07/2008
24Carboplatin (JM8)FDA LinkGeneric
03/2022 - 08/2006
23Docetaxel (Taxotere)FDA Link
10/2022 - 09/2006
22Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2022 - 08/2009
20Pharmaceutical PreparationsIBA
01/2022 - 06/2006
16AfatinibIBA
01/2022 - 09/2013
13NivolumabIBA
06/2022 - 10/2016
13Vinorelbine (Navelbine)FDA LinkGeneric
01/2022 - 08/2006
13Paclitaxel (Taxol)FDA LinkGeneric
10/2018 - 01/2006
12osimertinibIBA
01/2022 - 02/2018
11Bevacizumab (Avastin)FDA Link
01/2022 - 06/2012
11alectinibIBA
01/2021 - 06/2013
11Glucose (Dextrose)FDA LinkGeneric
02/2014 - 08/2010
11Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
02/2014 - 08/2010
9CrizotinibIBA
01/2021 - 06/2013
9Deoxyglucose (2 Deoxy D glucose)IBA
02/2014 - 08/2010
8Immune Checkpoint InhibitorsIBA
06/2022 - 01/2019
8Etoposide (VP 16)FDA LinkGeneric
05/2021 - 06/2010
8amrubicinIBA
03/2016 - 08/2007
8HexokinaseIBA
02/2014 - 01/2011
7pembrolizumabIBA
09/2022 - 01/2020
7B7-H1 AntigenIBA
02/2022 - 01/2019
7130-nm albumin-bound paclitaxelIBA
01/2021 - 06/2012
7GemcitabineFDA Link
06/2019 - 08/2006
7Irinotecan (Camptosar)FDA LinkGeneric
06/2014 - 03/2006
7Biological ProductsIBA
02/2014 - 08/2010
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2012
6RamucirumabIBA
01/2022 - 01/2016
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2014 - 05/2011
5atezolizumabIBA
05/2022 - 01/2020
5Anaplastic Lymphoma KinaseIBA
01/2021 - 05/2013
5Thymidylate SynthaseIBA
01/2014 - 09/2011
5TOR Serine-Threonine KinasesIBA
10/2013 - 01/2011
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2022 - 07/2009
4LigandsIBA
11/2021 - 02/2015
4Capsules (Microcapsules)IBA
01/2021 - 06/2013
4Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
01/2014 - 09/2011
4Orotate PhosphoribosyltransferaseIBA
01/2014 - 09/2011
4Amino Acid Transport Systems (Amino Acid Transporter)IBA
12/2011 - 12/2010
4Proteins (Proteins, Gene)FDA Link
07/2011 - 01/2008
3Keratins (Keratin)IBA
01/2022 - 01/2020
3Phosphopyruvate Hydratase (Enolase)IBA
07/2021 - 06/2012
3Cell-Free Nucleic AcidsIBA
02/2021 - 01/2012
3ParaffinIBA
01/2021 - 05/2014
3Formaldehyde (Formol)FDA Link
01/2021 - 05/2014
3AntiemeticsIBA
03/2019 - 10/2015
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 09/2011

Therapy/Procedure

90Drug Therapy (Chemotherapy)
09/2022 - 06/2002
70Therapeutics
01/2022 - 04/2004
30Radiotherapy
12/2021 - 07/2004
14Chemoradiotherapy
03/2022 - 11/2007
11Adjuvant Chemotherapy
12/2021 - 03/2009
5Immunotherapy
11/2021 - 01/2008
4Aftercare (After-Treatment)
01/2021 - 05/2011